Clinical relevance of time course of BNP levels in neonates with congenital heart diseases.
Cantinotti M, Passino C, Storti S, Ripoli A, Zyw L, Clerico A
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient age and gender on BNP levels in plasma from healthy infants and those with CHD.
Summary of Findings
In general, levels of BNP were significantly higher in plasma from CHD patients than from healthy controls (P<0.001). Specimens from individual CHD diagnosis groups had significantly higher average levels of BNP compared to controls except specimens from patients with RVPO or RVVO. Levels of BNP were not significantly different between specimens from male and female CHD patients. In specimens from healthy infants, BNP levels peaked on the second or third day of life and then progressively decreased, while BNP increased during the first 4 days of life and then stabilized at high values in specimens from patients with CHD. The authors report that not only did patient age and the presence of CHD affect BNP levels, but there was also an interaction between these two variables, and that the diagnostic accuracy and optimal cut-off values for the BNP assay are patient age-dependent.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
None (Fresh)Diagnoses
NormalOther diagnosesPlatforms
PeptideClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Left ventricular pressure overloadLeft ventricular volume overloadNormalRight ventricular pressure overloadRight ventricular volume overloadTransposition of the great arteriesUniventricular heartPreaquisition Patient age 0-500 hours oldPreaquisition Patient gender FemaleMale